Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation: An opportunity to improve rates of warfarin utilization

Michael H. Kim; Richard G. Trohman; Sara Christiansen; Manya R. Harsch; Ken Kinser; Michael J. Reiter; Julie Pfeiffer

doi:10.1111/j.1540-8159.2007.00714.x

Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation: An opportunity to improve rates of warfarin utilization

Michael H. Kim, Richard G. Trohman, Sara Christiansen, Manya R. Harsch, Ken Kinser, Michael J. Reiter, Julie Pfeiffer

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Atrial diagnostic data within implantable devices provide an opportunity to assess the frequency and quantity of atrial fibrillation (AF) episodes (AF burden) and its impact on appropriate warfarin anticoagulation. Cardiologists were given clinical scenarios to review with different types of pacemaker diagnostic data in an elderly patient with risk factors for stroke. AF specific data was associated with increased warfarin utilization, but only at intermediate rates. Potential reasons and clinical implications are discussed.

Original language	English (US)
Pages (from-to)	580-583
Number of pages	4
Journal	PACE - Pacing and Clinical Electrophysiology
Volume	30
Issue number	4
DOIs	https://doi.org/10.1111/j.1540-8159.2007.00714.x
State	Published - Apr 2007
Externally published	Yes

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine

Access to Document

10.1111/j.1540-8159.2007.00714.x

Cite this

@article{03c5b43316bd4075bd11b0bccfa68773,

title = "Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation: An opportunity to improve rates of warfarin utilization",

abstract = "Atrial diagnostic data within implantable devices provide an opportunity to assess the frequency and quantity of atrial fibrillation (AF) episodes (AF burden) and its impact on appropriate warfarin anticoagulation. Cardiologists were given clinical scenarios to review with different types of pacemaker diagnostic data in an elderly patient with risk factors for stroke. AF specific data was associated with increased warfarin utilization, but only at intermediate rates. Potential reasons and clinical implications are discussed.",

author = "Kim, {Michael H.} and Trohman, {Richard G.} and Sara Christiansen and Harsch, {Manya R.} and Ken Kinser and Reiter, {Michael J.} and Julie Pfeiffer",

year = "2007",

month = apr,

doi = "10.1111/j.1540-8159.2007.00714.x",

language = "English (US)",

volume = "30",

pages = "580--583",

journal = "PACE - Pacing and Clinical Electrophysiology",

issn = "0147-8389",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation

T2 - An opportunity to improve rates of warfarin utilization

AU - Kim, Michael H.

AU - Trohman, Richard G.

AU - Christiansen, Sara

AU - Harsch, Manya R.

AU - Kinser, Ken

AU - Reiter, Michael J.

AU - Pfeiffer, Julie

PY - 2007/4

Y1 - 2007/4

N2 - Atrial diagnostic data within implantable devices provide an opportunity to assess the frequency and quantity of atrial fibrillation (AF) episodes (AF burden) and its impact on appropriate warfarin anticoagulation. Cardiologists were given clinical scenarios to review with different types of pacemaker diagnostic data in an elderly patient with risk factors for stroke. AF specific data was associated with increased warfarin utilization, but only at intermediate rates. Potential reasons and clinical implications are discussed.

AB - Atrial diagnostic data within implantable devices provide an opportunity to assess the frequency and quantity of atrial fibrillation (AF) episodes (AF burden) and its impact on appropriate warfarin anticoagulation. Cardiologists were given clinical scenarios to review with different types of pacemaker diagnostic data in an elderly patient with risk factors for stroke. AF specific data was associated with increased warfarin utilization, but only at intermediate rates. Potential reasons and clinical implications are discussed.

UR - http://www.scopus.com/inward/record.url?scp=34247129603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247129603&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.2007.00714.x

DO - 10.1111/j.1540-8159.2007.00714.x

M3 - Article

C2 - 17437588

AN - SCOPUS:34247129603

SN - 0147-8389

VL - 30

SP - 580

EP - 583

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

IS - 4

ER -

Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation: An opportunity to improve rates of warfarin utilization

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this